Takaisin Tulosta

Epilepsiat (aikuiset), näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
25.2.2020

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Epilepsiat (aikuiset) «Epilepsiat (aikuiset)»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Alper K, Schwartz KA, Kolts RL ym. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007;62:345-54 «PMID: 17223086»PubMed
  2. Andersohn F, Schade R, Willich SN ym. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010;75:335-40 «PMID: 20660863»PubMed
  3. Arana A, Wentworth CE, Ayuso-Mateos JL ym. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010;363:542-51 «PMID: 20818889»PubMed
  4. Arroyo S, Dodson WE, Privitera MD ym. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005;112:214-22 «PMID: 16146489»PubMed
  5. Baulac M, Brodie MJ, Patten A ym. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol 2012;11:579-88 «PMID: 22683226»PubMed
  6. Baulac M, Rosenow F, Toledo M ym. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol 2017;16:43-54 «PMID: 27889312»PubMed
  7. Beghi E. Prognosis of first seizure. Kirjassa Prognosis of epilepsies. Jallon P, Berg A, Dulac O, Hauser A (toim.). John Libbey Eurotext, 2003:21-8
  8. Ben-Menachem E, Biton V, Jatuzis D ym. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007;48:1308-17 «PMID: 17635557»PubMed
  9. Besag FM, Wallace SJ, Dulac O ym. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 1995;127:991-7 «PMID: 8523205»PubMed
  10. Bradley PM, Lindsay B, Fleeman N. Care delivery and self management strategies for adults with epilepsy. Cochrane Database Syst Rev 2016;2:CD006244 «PMID: 26842929»PubMed
  11. Bresnahan R, Hounsome J, Jette N ym. Topiramate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev 2019;10:CD001417 «PMID: 31642054»PubMed
  12. Bresnahan R, Martin-McGill KJ, Hutton JL ym. Tiagabine add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev 2019;10:CD001908 «PMID: 31608990»PubMed
  13. Brigo F, Igwe SC, Bragazzi NL. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. Cochrane Database Syst Rev 2017;5:CD010483 «PMID: 28521067»PubMed
  14. Brigo F, Lattanzi S, Igwe SC ym. Zonisamide add-on therapy for focal epilepsy. Cochrane Database Syst Rev 2018;10:CD001416 «PMID: 30335200»PubMed
  15. Brodie MJ, Chadwick DW, Anhut H ym. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000 «PMID: 12199724»PubMed
  16. Brodie MJ, Lerche H, Gil-Nagel A ym. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology 2010;75:1817-24 «PMID: 20944074»PubMed
  17. Brodie MJ, Perucca E, Ryvlin P ym. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68:402-8 «PMID: 17283312»PubMed
  18. Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy. Brain Dev 1999;21:303-6 «PMID: 10413016»PubMed
  19. Chadwick DW, Anhut H, Greiner MJ ym. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998;51:1282-8 «PMID: 9818846»PubMed
  20. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2005;:CD001416 «PMID: 16235282»PubMed
  21. Chaisewikul R, Privitera MD, Hutton JL ym. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database Syst Rev 2001;:CD001901 «PMID: 11279737»PubMed
  22. Chang XC, Yuan H, Wang Y ym. Eslicarbazepine acetate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2017;10:CD008907 «PMID: 29067682»PubMed
  23. Chiron C, Marchand MC, Tran A ym. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-42 «PMID: 11089822»PubMed
  24. Chung S, Sperling MR, Biton V ym. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010;51:958-67 «PMID: 20132285»PubMed
  25. Devinsky O, Cross JH, Laux L ym. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med 2017;376:2011-2020 «PMID: 28538134»PubMed
  26. Devinsky O, Patel AD, Cross JH ym. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. N Engl J Med 2018;378:1888-1897 «PMID: 29768152»PubMed
  27. Engel J Jr, McDermott MP, Wiebe S ym. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307:922-30 «PMID: 22396514»PubMed
  28. Favale E, Audenino D, Cocito L ym. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003;12:316-8 «PMID: 12810346»PubMed
  29. Favale E, Rubino V, Mainardi P ym. Anticonvulsant effect of fluoxetine in humans. Neurology 1995;45:1926-7 «PMID: 7477995»PubMed
  30. Fiest KM, Dykeman J, Patten SB ym. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013;80:590-9 «PMID: 23175727»PubMed
  31. Fisher R, Salanova V, Witt T ym. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51:899-908 «PMID: 20331461»PubMed
  32. Frank LM, Enlow T, Holmes GL ym. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9 «PMID: 10403222»PubMed
  33. French JA, Abou-Khalil BW, Leroy RF ym. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology 2011;76:1555-63 «PMID: 21451152»PubMed
  34. French JA, Krauss GL, Biton V ym. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012;79:589-96 «PMID: 22843280»PubMed
  35. French JA, Krauss GL, Steinhoff BJ ym. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia 2013;54:117-25 «PMID: 22905857»PubMed
  36. French JA, Krauss GL, Wechsler RT ym. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial. Neurology 2015;85:950-7 «PMID: 26296511»PubMed
  37. Gaily E, Jonsson H, Lappi M. Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia 2009;50:206-16 «PMID: 19215279»PubMed
  38. Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 2006;:CD001031 «PMID: 16437428»PubMed
  39. Genton P, Gelisse P, Thomas P ym. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9 «PMID: 11071486»PubMed
  40. Gilliam FG, Veloso F, Bomhof MA ym. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003;60:196-202 «PMID: 12552030»PubMed
  41. Glauser T, Kluger G, Sachdeo R ym. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008;70:1950-8 «PMID: 18401024»PubMed
  42. Glauser TA, Cnaan A, Shinnar S ym. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-9 «PMID: 20200383»PubMed
  43. Glauser TA, Cnaan A, Shinnar S ym. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013;54:141-55 «PMID: 23167925»PubMed
  44. Guerrini R, Tonnelier S, d´Athis P, Rey E, Vincent J, Pons G. Stiripentol in severe myoclonic epilepsy in infancy (SMEI): a placebo-controlled Italian trial. Epilepsia 2002;43(Suppl 8):155
  45. Halász P, Kälviäinen R, Mazurkiewicz-Beldzinska M ym. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia 2009;50:443-53 «PMID: 19183227»PubMed
  46. Jette NJ, Marson AG, Hutton JL. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2002;:CD001417 «PMID: 12137625»PubMed
  47. Karouni M, Arulthas S, Larsson PG ym. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010;66:1151-60 «PMID: 20669014»PubMed
  48. King MA, Newton MR, Jackson GD ym. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-11 «PMID: 9759742»PubMed
  49. Kluger G, Glauser T, Krauss G ym. Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. Acta Neurol Scand 2010;122:202-8 «PMID: 20199521»PubMed
  50. Krauss GL, Serratosa JM, Villanueva V ym. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 2012;78:1408-15 «PMID: 22517103»PubMed
  51. Kwan P, Brodie MJ, Kälviäinen R ym. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. Lancet Neurol 2011;10:881-90 «PMID: 21889410»PubMed
  52. Kälviäinen R, Nousiainen I, Mäntyjärvi M ym. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology 1999;53:922-6 «PMID: 10496247»PubMed
  53. Lattanzi S, Cagnetti C, Foschi N ym. Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis. Neurology 2016;86:1344-1352 «PMID: 26944275»PubMed
  54. Leone MA, Solari A, Beghi E ym. Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy. Neurology 2006;67:2227-9 «PMID: 17190950»PubMed
  55. Lozsadi D, Hemming K, Marson AG. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2008;:CD005612 «PMID: 18254084»PubMed
  56. Macrodimitris S, Sherman EM, Forde S ym. Psychiatric outcomes of epilepsy surgery: a systematic review. Epilepsia 2011;52:880-90 «PMID: 21426324»PubMed
  57. Maguire MJ, Hemming K, Wild JM ym. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 2010;51:2423-31 «PMID: 21070215»PubMed
  58. Marson AG, Al-Kharusi AM, Alwaidh M ym. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15 «PMID: 17382827»PubMed
  59. Marson AG, Al-Kharusi AM, Alwaidh M ym. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26 «PMID: 17382828»PubMed
  60. Marson AG, Kadir ZA, Hutton JL ym. Gabapentin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2000;:CD001415 «PMID: 10908495»PubMed
  61. Marson AG, Williamson PR, Hutton JL ym. Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database Syst Rev 2000;:CD001030 «PMID: 10908558»PubMed
  62. Martin-McGill KJ, Jackson CF, Bresnahan R ym. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 2018;11:CD001903 «PMID: 30403286»PubMed
  63. Mentari E, Hughes A, Feeney III J ym. Antiepileptic drugs and suicidality. Statistical review and evaluation. Date 23.5.2008
  64. Morrell MJ, RNS System in Epilepsy Study Group.. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77:1295-304 «PMID: 21917777»PubMed
  65. Muller M, Marson AG, Williamson PR. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev 2006;:CD003615 «PMID: 16625587»PubMed
  66. Nevitt SJ, Marson AG, Tudur Smith C. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 2018;10:CD001904 «PMID: 30353945»PubMed
  67. Nevitt SJ, Marson AG, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 2019;7:CD001911 «PMID: 31318037»PubMed
  68. Nevitt SJ, Marson AG, Weston J ym. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 2018;8:CD001769 «PMID: 30091458»PubMed
  69. Nevitt SJ, Tudur Smith C, Marson AG. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 2018;10:CD003615 «PMID: 30350354»PubMed
  70. Nevitt SJ, Tudur Smith C, Weston J ym. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 2018;6:CD001031 «PMID: 29952431»PubMed
  71. Nikanorova M, Brandt C, Auvin S ym. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study. Epilepsy Behav 2017;76:63-70 «PMID: 28927712»PubMed
  72. Ohtsuka Y, Yoshinaga H, Shirasaka Y ym. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial. Epilepsy Res 2016;121:1-7 «PMID: 26827266»PubMed
  73. Ohtsuka Y, Yoshinaga H, Shirasaka Y ym. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan. Epilepsy Res 2014;108:1627-36 «PMID: 25219353»PubMed
  74. Olesen JB, Hansen PR, Erdal J ym. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 2010;19:518-24 «PMID: 20235081»PubMed
  75. Panebianco M, Al-Bachari S, Weston J ym. Gabapentin add-on treatment for drug-resistant focal epilepsy. Cochrane Database Syst Rev 2018;10:CD001415 «PMID: 30357813»PubMed
  76. Panebianco M, Bresnahan R, Hemming K ym. Pregabalin add-on for drug-resistant focal epilepsy. Cochrane Database Syst Rev 2019;7:CD005612 «PMID: 31287157»PubMed
  77. Panebianco M, Rigby A, Weston J ym. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2015;:CD002896 «PMID: 25835947»PubMed
  78. Patorno E, Bohn RL, Wahl PM ym. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010;303:1401-9 «PMID: 20388896»PubMed
  79. Pereira J, Marson AG, Hutton JL. Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2002;:CD001908 «PMID: 12137637»PubMed
  80. Porter RJ, Partiot A, Sachdeo R ym. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 2007;68:1197-204 «PMID: 17420403»PubMed
  81. Privitera MD, Brodie MJ, Mattson RH ym. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003;107:165-75 «PMID: 12614309»PubMed
  82. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2001;:CD001909 «PMID: 11687001»PubMed
  83. Ramaratnam S, Panebianco M, Marson AG. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2016;:CD001909 «PMID: 27329345»PubMed
  84. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group) Neurology 1993;43:478-83 «PMID: 8450987»PubMed
  85. Riikonen R, Rener-Primec Z, Carmant L ym. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. Dev Med Child Neurol 2015;57:60-7 «PMID: 25145415»PubMed
  86. Rowan AJ, Ramsay RE, Collins JF ym. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73 «PMID: 15955935»PubMed
  87. Saetre E, Perucca E, Isojärvi J ym. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-302 «PMID: 17561956»PubMed
  88. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2001;:CD000173 «PMID: 11687070»PubMed
  89. Schwarz MD, Li M, Tsao J ym. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience. Epilepsy Behav 2016;57:29-33 «PMID: 26921595»PubMed
  90. Sharpe DV, Patel AD, Abou-Khalil B ym. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 2008;17:64-8 «PMID: 17692537»PubMed
  91. Specchio LM, Iudice A, Specchio N ym. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004;27:133-6 «PMID: 15190237»PubMed
  92. Taylor S, Tudur Smith C, Williamson PR ym. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev 2001;:CD002217 «PMID: 11687150»PubMed
  93. Téllez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain 2005;128:1188-98 «PMID: 15758038»PubMed
  94. Tellez-Zenteno JF, Patten SB, Jetté N ym. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007;48:2336-44 «PMID: 17662062»PubMed
  95. Thiele EA, Marsh ED, French JA ym. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391:1085-1096 «PMID: 29395273»PubMed
  96. Thompson K, Pohlmann-Eden B, Campbell LA ym. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database Syst Rev 2015;:CD009900 «PMID: 26259048»PubMed
  97. Trinka E, Ben-Menachem E, Kowacs PA ym. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study. Epilepsia 2018;59:479-491 «PMID: 29369348»PubMed
  98. Trinka E, Marson AG, Van Paesschen W ym. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. J Neurol Neurosurg Psychiatry 2013;84:1138-47 «PMID: 22933814»PubMed
  99. Tudur Smith C, Marson AG, Clough HE ym. Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev 2002;:CD001911 «PMID: 12076427»PubMed
  100. Tudur Smith C, Marson AG, Williamson PR. Carbamazepine versus phenobarbitone monotherapy for epilepsy. Cochrane Database Syst Rev 2003;:CD001904 «PMID: 12535420»PubMed
  101. Tudur Smith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev 2001;:CD001769 «PMID: 11687121»PubMed
  102. Wen X, Meador KJ, Loring DW ym. Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy? Epilepsy Behav 2010;19:494-500 «PMID: 20880757»PubMed
  103. Verrotti A, Cerminara C, Coppola G ym. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol 2008;50:29-32 «PMID: 18173626»PubMed
  104. Wiebe S, Blume WT, Girvin JP ym. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-8 «PMID: 11484687»PubMed
  105. Wohlrab G, Leiba H, Kästle R ym. Vigabatrin therapy in infantile spasms: solving one problem and inducing another? Epilepsia 2009;50:2006-8 «PMID: 19682036»PubMed